Added to YB: 2023-02-03
Pitch date: 2023-02-03
MGTA [bullish]
Magenta Therapeutics, Inc.
-12.55%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of September 11, 2023, Magenta Therapeutics, Inc. was acquired by Dianthus Therapeutics, Inc., in a reverse merger transaction.
Market Cap
$42.2M
Pitch Price
$12.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.62
P/E
-0.61
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Magenta Therapeutics: Trading Well Below Cash, Strategic Alternatives
A summary for this pitch has not been created yet.
Read full article (1 min)